These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 8106389
1. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme. Schroeder JJ, Crane HM, Xia J, Liotta DC, Merrill AH. J Biol Chem; 1994 Feb 04; 269(5):3475-81. PubMed ID: 8106389 [Abstract] [Full Text] [Related]
2. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ. Merrill AH, van Echten G, Wang E, Sandhoff K. J Biol Chem; 1993 Dec 25; 268(36):27299-306. PubMed ID: 8262970 [Abstract] [Full Text] [Related]
3. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme. Wang E, Norred WP, Bacon CW, Riley RT, Merrill AH. J Biol Chem; 1991 Aug 05; 266(22):14486-90. PubMed ID: 1860857 [Abstract] [Full Text] [Related]
4. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins. Riley RT, Wang E, Schroeder JJ, Smith ER, Plattner RD, Abbas H, Yoo HS, Merrill AH. Nat Toxins; 1996 Aug 05; 4(1):3-15. PubMed ID: 8680751 [Abstract] [Full Text] [Related]
5. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice. Tsunoda M, Sharma RP, Riley RT. J Biochem Mol Toxicol; 1998 Aug 05; 12(5):281-9. PubMed ID: 9664234 [Abstract] [Full Text] [Related]
6. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs. Riley RT, An NH, Showker JL, Yoo HS, Norred WP, Chamberlain WJ, Wang E, Merrill AH, Motelin G, Beasley VR. Toxicol Appl Pharmacol; 1993 Jan 05; 118(1):105-12. PubMed ID: 8430417 [Abstract] [Full Text] [Related]
7. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. Riley RT, Hinton DM, Chamberlain WJ, Bacon CW, Wang E, Merrill AH, Voss KA. J Nutr; 1994 Apr 05; 124(4):594-603. PubMed ID: 8145083 [Abstract] [Full Text] [Related]
8. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. Riley RT, Enongene E, Voss KA, Norred WP, Meredith FI, Sharma RP, Spitsbergen J, Williams DE, Carlson DB, Merrill AH. Environ Health Perspect; 2001 May 05; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699 [Abstract] [Full Text] [Related]
9. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. Wang E, Ross PF, Wilson TM, Riley RT, Merrill AH. J Nutr; 1992 Aug 05; 122(8):1706-16. PubMed ID: 1640265 [Abstract] [Full Text] [Related]
10. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. Yoo HS, Norred WP, Wang E, Merrill AH, Riley RT. Toxicol Appl Pharmacol; 1992 May 05; 114(1):9-15. PubMed ID: 1585377 [Abstract] [Full Text] [Related]
11. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity. Yoo HS, Norred WP, Showker J, Riley RT. Toxicol Appl Pharmacol; 1996 Jun 05; 138(2):211-8. PubMed ID: 8658522 [Abstract] [Full Text] [Related]
12. Disruption of sphingolipid metabolism in non-human primates consuming diets of fumonisin-containing Fusarium moniliforme culture material. Shephard GS, van der Westhuizen L, Thiel PG, Gelderblom WC, Marasas WF, van Schalkwyk DJ. Toxicon; 1996 May 05; 34(5):527-34. PubMed ID: 8783447 [Abstract] [Full Text] [Related]
13. Sphingoid bases and their phosphates: transient activation and delayed repression of protein kinase C isoforms and their possible involvement in fumonisin B1 cytotoxicity. Gopee NV, Sharma RP. Toxicology; 2003 May 03; 187(2-3):239-50. PubMed ID: 12699912 [Abstract] [Full Text] [Related]
14. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice. Voss KA, Riley RT, Bacon CW, Chamberlain WJ, Norred WP. Nat Toxins; 1996 May 03; 4(1):16-23. PubMed ID: 8680749 [Abstract] [Full Text] [Related]
15. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships. Norred WP, Plattner RD, Dombrink-Kurtzman MA, Meredith FI, Riley RT. Toxicol Appl Pharmacol; 1997 Nov 03; 147(1):63-70. PubMed ID: 9356308 [Abstract] [Full Text] [Related]
16. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Soriano JM, González L, Catalá AI. Prog Lipid Res; 2005 Nov 03; 44(6):345-56. PubMed ID: 16266752 [Abstract] [Full Text] [Related]
17. Mechanism of the mitogenic and carcinogenic action of fumonisin B1, a mycotoxin. Wolf G. Nutr Rev; 1994 Jul 03; 52(7):246-7. PubMed ID: 8090377 [Abstract] [Full Text] [Related]
18. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases. Schmelz EM, Dombrink-Kurtzman MA, Roberts PC, Kozutsumi Y, Kawasaki T, Merrill AH. Toxicol Appl Pharmacol; 1998 Feb 03; 148(2):252-60. PubMed ID: 9473533 [Abstract] [Full Text] [Related]
19. Fumonisin B(1) induces apoptosis in LLC-PK(1) renal epithelial cells via a sphinganine- and calmodulin-dependent pathway. Kim MS, Lee DY, Wang T, Schroeder JJ. Toxicol Appl Pharmacol; 2001 Oct 15; 176(2):118-26. PubMed ID: 11601888 [Abstract] [Full Text] [Related]
20. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser; 2001 Dec 15; (496):1-352. PubMed ID: 11852482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]